Beta Testing of Ultra-High-Density MEA System Featuring Approximately 237,000 Electrodes Begins

High-Resolution Visualization of Cellular Activity to Accelerate Neuroscience and Cardiac Research

Vitrovo Inc. (hereinafter "Vitrovo") has announced a joint press release with Sony Semiconductor Solutions Corporation ("Sony") and SCREEN Holdings Co., Ltd. ("SCREEN") regarding a newly developed MEA system that utilizes a high-density CMOS-MEA equipped with approximately 237,000 electrodes.

This next-generation system enables ultra-high-density and high-resolution measurement and recording of electrical activity in cultured cells—capabilities that were previously difficult to achieve. The technology is expected to make a significant impact in neurological and cardiac disease research and drug discovery.

As part of this collaboration, Vitrovo provides consulting services for cell culture protocols and custom data analysis to support the adoption and application of the system. In addition, we have launched contract testing services that allow users to evaluate the system’s performance and suitability for their research needs.

Through this initial trial offering, we aim to gather real-world feedback, accelerate further system development, and explore market needs. These efforts will drive our goal of commercializing CMOS-MEA–based MEA systems for broad use in life sciences research.

Please refer to the full press release via the link below: